# David Schoenfeld

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-schoenfeld/

## Facts

| Field | Value |
| --- | --- |
| Citations | 54,951 |
| Field | Amyotrophic Lateral Sclerosis Research |
| h-index | 114 |
| i10-index | 318 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5044481779 |
| ORCID iD | https://orcid.org/0000-0003-1948-3711 |
| Works | 453 |

## Researcher papers

- [Genomic responses in mouse models poorly mimic human inflammatory diseases](https://scholariq.org/papers/genomic-responses-in-mouse-models-poorly-mimic-human-inflammatory-diseases/)
- [Driving Pressure and Survival in the Acute Respiratory Distress Syndrome](https://scholariq.org/papers/driving-pressure-and-survival-in-the-acute-respiratory-distress-syndrome/)
- [Translating the A1C Assay Into Estimated Average Glucose Values](https://scholariq.org/papers/translating-the-a1c-assay-into-estimated-average-glucose-values/)
- [Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and Zalcitabine](https://scholariq.org/papers/treatment-of-human-immunodeficiency-virus-infection-with-saquinavir-zidovudine/)
- [Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis](https://scholariq.org/papers/trial-of-sodium-phenylbutyrate-taurursodiol-for-amyotrophic-lateral-sclerosis/)
- [Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19](https://scholariq.org/papers/effect-of-hydroxychloroquine-on-clinical-status-at-14-days-in-hospitalized/)
- [Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG](https://scholariq.org/papers/creatine-in-huntington-disease-is-safe-tolerable-bioavailable-in-brain-and/)
- [A clinical trial of creatine in ALS](https://scholariq.org/papers/a-clinical-trial-of-creatine-in-als/)
- [The PRO-ACT database](https://scholariq.org/papers/the-pro-act-database/)
- [Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/safety-and-efficacy-of-ceftriaxone-for-amyotrophic-lateral-sclerosis-a-multi/)
- [A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis](https://scholariq.org/papers/a-randomized-placebo-controlled-trial-of-topiramate-in-amyotrophic-lateral/)
- [Long‐term survival of participants in the <scp>CENTAUR</scp> trial of sodium phenylbutyrate‐taurursodiol in <scp>amyotrophic lateral sclerosis</scp>](https://scholariq.org/papers/long-term-survival-of-participants-in-the-scp-centaur-scp-trial-of-sodium/)

## Researcher topics

- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Statistical Methods and Inference](https://scholariq.org/topics/statistical-methods-and-inference/)
- [Respiratory Support and Mechanisms](https://scholariq.org/topics/respiratory-support-and-mechanisms/)
- [Advanced Causal Inference Techniques](https://scholariq.org/topics/advanced-causal-inference-techniques/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.